Crohn's Disease Clinical Trials in Chicago

Showing 1-20 of 78 trials

Treatment of Moderate to Severe Refractory Crohn's Disease

NCT06721962

This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of TRX103 are when administered to individuals with CD.

Crohns Disease

Tr1X, Inc.39 participantsStarted May 2025

Scottsdale, Arizona, United States • Sacramento, California, United States • San Francisco, California, United States +10 more locations

TERMINATEDPhase 32.2 miles

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

NCT03467958

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.

Crohn Disease

Celgene854 participantsStarted Aug 2018

Peoria, Arizona, United States • Scottsdale, Arizona, United States • North Little Rock, Arkansas, United States +763 more locations

Treatment of Moderate to Severe Refractory Crohn's Disease

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Crohn's Disease Trials in Other Cities

A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)

A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)

Other Conditions in Chicago